Variant report
Variant | esv3324546 |
---|---|
Chromosome Location | chr3:109991733-109992234 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2712998 | chr3:109991739-109991740 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs573430263 | chr3:109991808-109991809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563582414 | chr3:109991830-109991831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2614694 | chr3:109991870-109991871 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs552484388 | chr3:109991900-109991901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4682570 | chr3:109991904-109991905 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs11714384 | chr3:109991906-109991907 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs143286733 | chr3:109991910-109991911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568078510 | chr3:109991937-109991938 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537016501 | chr3:109991942-109991943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188431265 | chr3:109991969-109991970 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111492765 | chr3:109991974-109991975 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113727142 | chr3:109992013-109992014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111441961 | chr3:109992022-109992023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs386664543 | chr3:109992024-109992025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372980928 | chr3:109992025-109992026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11714431 | chr3:109992026-109992027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs116015686 | chr3:109992032-109992033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34794966 | chr3:109992039-109992040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555210680 | chr3:109992062-109992063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574492846 | chr3:109992105-109992106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2614693 | chr3:109992184-109992185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs71131913 | chr3:109992222-109992223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs63533263 | chr3:109992223-109992224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:109985000-109992000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr3:109990600-109992200 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr3:109990600-109992400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr3:109990600-109992400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr3:109990800-109992200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr3:109990800-109992600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr3:109991000-109992200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr3:109991000-109992200 | Enhancers | Fetal Heart | heart |
9 | chr3:109991000-109992600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr3:109991000-109993000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:109992000-109992200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |